DocuSign's AI Pivot Just Reached the Financials — and the Stock Is Paying Up for It

DocuSign's product was always the document — the thing you clicked through, signed, and filed. For years that settled into a slow, cash-rich middle age: revenue growth drifted into the single digits, and the stock's multiple compressed. So why have shares climbed roughly 43% in the four months through this week, and another 6% on a strong Friday, to about $70 — well off a 52-week low near $40?

The short answer is that its AI story stopped being a promise and touched the income statement.

In the quarter ended July 31, reported early this month, revenue rose about 9% from a year earlier to $875.7 million, adjusted earnings came in at $1.16 a share, up 26%, and free cash flow hit $296 million at a 34% margin. Fine numbers, but nothing that alone justifies a re-rating. The line management chose to publish was the one that mattered: Intelligent Agreement Management — the AI platform that catalogs, analyzes, and acts on contracts rather than just signing them — now accounts for , up from 12.6% the prior quarter, and the company is guiding it to 18–19% by year-end. It raised full-year guidance on the strength of that climb.

That single datapoint is the transition point in DocuSign's story, and it's worth slowing down to see why.

Why IAM is different from e-signature

E-signature was a transaction: a document goes out, comes back signed, and the value is done. IAM is a system of record. The company's pitch is that a contract isn't a finished artifact — it's an obligation that has to be renewed, renegotiated, monitored, and audited. Docusign says more than 300 million documents have been ingested through its Agreement Manager, and it points to a proprietary dataset of over 200 million consented agreements that gives it a claimed precision edge and a large processing-cost advantage over AI models trained only on public contracts.

The AI layer — an engine called Iris — lets customers ask questions of their contract stack in plain language, run redlines, and trigger renewals. Its agents sit in Agent Studio so teams can build their own workflows. Management says user testing showed the assistant roughly halves the time to review and finalize an agreement like an NDA. What sold the market this quarter is distribution: an MCP server that connects Docusign's agreement intelligence out to other companies' AI agents — ChatGPT, Anthropic's Claude, Gemini, Microsoft Copilot. Active MCP accounts more than quadrupled in the quarter, and the server reaches general availability at the end of September.

In other words, DocuSign is repositioning from "the company where you sign the document" to "the agreement layer the AI agents of the world draw on." Under CEO Allan Thygesen, that's the bet: IAM as an "agreement system of action," with the e-signature business as the installed base it grows from.

The honest reading of the numbers

This is exactly the kind of roadmap-to-revenue moment the discipline rewards: a claimed milestone has reached the financials at scale, with a number attached. But read the growth with the same care. Revenue is still growing about 9%. The company raised its ARR growth guidance for the year to 8.5–9% — a reacceleration from last year's 8%, not a breakout. The re-rate has carried the stock's price-to-sales to roughly 3.9x and its EV/EBITDA to about 31x. That is still far cheaper on sales than the unprofitable, higher-growth software names like Datadog (roughly 21x sales) — but those names grow revenue several times as fast. The market is now paying for the trajectory of IAM's share of ARR, not for the current level of growth.

What actually protects the downside is the financial engine underneath. Cash and investments sit around $973 million with zero debt. DocuSign bought back $306.5 million of stock in the quarter, cutting the diluted share count 8% year over year to 193 million, with $2.1 billion still authorized. Dollar net retention ticked up to 103%, and customers spending over $300,000 a year grew 14% to about 1,300. For a stock at roughly 3.9x sales, that combination — a profitable, cash-generative installed base plus an active buyback floor — is not a fragile AI narrative. It's a real business paying for a turnaround out of its own cash flow.

The judgment

The question for a buyer is no longer whether the AI story is real. On the evidence, it has started to show up where it counts: IAM's share of ARR climbing from 12.6% to 15.1% in a single quarter, guided higher for the year. The question is whether the price now embeds only the first chapter. Docusign has re-rated roughly 43% in four months on a path that, even if the guidance holds, leaves the company growing at a high-single-digit rate by year-end — with IAM expected to be about 18–19% of ARR, not a majority, and not yet a growth rate that separates it dramatically from the era that preceded it.

That's the opportunity-cost test, and it's where the caution lives. A turnaround that reaches the financials is the setup worth owning. A turnaround the market has already re-rated — before the IAM share of ARR has translated into a clearly faster top line — is a different risk-reward than the one that existed in the $40s. The fat free cash flow, the buyback, and net cash give holders a wide landing zone. But the additional return from here rides on IAM continuing to eat a bigger share of a business still growing 9% — and that is a claim the next several quarters have to prove, not the quarter we just saw.